Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
filingDate |
2003-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b89bc641fbf156ea7382fbe8f02dd27b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ee503e0554f7c97094831ddfbca262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9454415ec1cb4de43ddc58d1030a7a5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a72de7c64307738370940cc1a71c4028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c3de579ca27d2823993550a324a36a |
publicationDate |
2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1496931-A1 |
titleOfInvention |
Methods for treating an autoimmune disease using a soluble ctla4 molecule and a dmard or nsaid |
abstract |
The present invention relates to compositions and methods for treating immune system diseases such as rheumatic disease, by administering to a subject soluble CTLA4 molecules that block endogenous B7 molecules from binding their ligands, alone, or in conjunction with other agents including Disease Modifying Anti-Rheumatic Drugs (DMARDs). |
priorityDate |
2002-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |